Enterprise Security Leaders See AI and Machine Learning as the Biggest Near-Term Cyberthreats, ISG Study Finds
A global survey of executives finds cybersecurity investments are more focused on detection and protection…
Machine Learning
Anonos Named in Seven Gartner 2023 Hype Cycle™ Reports
Anonos highlighted as a leading vendor in seven Gartner 2023 Hype Cycle reports for its…
Parexel and Partex Announce Innovative Alliance Leveraging Artificial Intelligence and Big Data to Accelerate Drug Discovery and Development
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand…
Parexel and Partex Announce Innovative Alliance Leveraging Artificial Intelligence and Big Data to Accelerate Drug Discovery and Development
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand…
Gradiant Launches Turing, an Independent End-to-End Digital Solutions Provider for the Water Industry
Turing will deliver AI and IoT solutions across water and wastewater treatment and distribution systems….
MariaDB Announces Third Quarter Fiscal 2023 Financial Results
REDWOOD CITY, Calif. & DUBLIN–(BUSINESS WIRE)–MariaDB plc (NYSE: MRDB) today announced its financial results for…
Bentley Systems’ iTwin Ventures Acquires Blyncsy, Breakthrough Innovator in AI Services for Transportation Operations and Maintenance
To Broaden and Accelerate Infrastructure Asset Analytics EXTON, Pa.–(BUSINESS WIRE)–#engineering–Bentley Systems, Incorporated (Nasdaq: BSY), the…
Media Alert: Intel oneAPI DevSummit for AI 2023
Join Intel for a two-day virtual event to learn more about multiarchitecture software development for…
Oxford Health Founder, Steve Wiggins, launches a new type of health insurance plan with nirvanaHealth’s Aria platform on Microsoft Azure
SOUTHBOROUGH, Mass.–(BUSINESS WIRE)–Oxbridge Health (“Oxbridge”) will leverage nirvanaHealth’s Aria Payer & PBM platform to administer…
Lantern Pharma Receives Notice of US Patent Allowance for Drug Candidate LP-184 for the Treatment of Rare Pediatric Brain Cancer, ATRT
LP-184 is the first of Lantern’s drug candidates developed by leveraging Lantern’s AI platform, RADR®…
BioXcel Therapeutics Reports Second Quarter 2023 Financial Results and Announces Strategic Reprioritization
Business to prioritize high-potential agitation market opportunities for BXCL501 in bipolar disorders, schizophrenia, and Alzheimer’s…
BioXcel Therapeutics Reports Second Quarter 2023 Financial Results and Announces Strategic Reprioritization
Business to prioritize high-potential agitation market opportunities for BXCL501 in bipolar disorders, schizophrenia, and Alzheimer’s…
CAS and Molecule.one Announce a Strategic Collaboration to Accelerate Drug Discovery
The two organizations are joining forces to develop pioneering AI-based solutions for efficient chemical synthesis…
Abnormal Security Recognized as a Leader in AI, Cloud, and Cybersecurity by Industry and Customers Alike
Abnormal Debuts on the Forbes Cloud 100 and Secures Additional Recognition from Redpoint Ventures, Bloomberg,…
Snorkel AI deepens partnership with Google Cloud to help enterprises unlock the potential of large language models
Leader in data-centric AI launches offering on Google Cloud Marketplace and expands collaboration to Vertex…
Monte Rosa Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
On track to present initial data from Phase 1/2 clinical trial of MRT-2359 for MYC-driven…
Monte Rosa Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
On track to present initial data from Phase 1/2 clinical trial of MRT-2359 for MYC-driven…
Lookout Introduces Gen AI Assistant ‘Lookout SAIL’ to Transform Cybersecurity Operations
Lookout SAIL is designed to empower cyber defenders by leveraging generative AI technology to enhance…
AI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against Cancer
Cutting-edge AI/machine learning technology with validation in humans for early diagnosis of lung cancer In…
AI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against Cancer
Cutting-edge AI/machine learning technology with validation in humans for early diagnosis of lung cancer In…